Skip to main navigation Skip to search Skip to main content

A model of polymicrobial catheter-associated urinary tract infection reveals biofilm-mediated modulation of treatment efficacy

  • The Department of Clinical Infection
  • Microbiology Society
  • Clinical and Diagnostic Immunology
  • University of Liverpool
  • Pathogen Genomics Unit
  • United Kingdom Health Security Agency

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: Catheter-associated urinary tract infections (CAUTI) are among the most prevalent healthcare-associated infections and an important site for development and spread of antimicrobial resistance. Although CAUTI are frequently polymicrobial, the majority of research focuses on individual pathogens in monoculture, largely due to a lack of representative and tractable models.

AIMS: The aim of this study was to develop a tractable and reproducible model of polymicrobial CAUTI.

METHODS: Here we describe the use of an in vitro model of the catheterized urinary tract to generate polymicrobial communities encompassing common uropathogens (Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, and Proteus mirabilis), in an environment representative of the catheterized urinary tract.

RESULTS AND CONCLUSIONS: We show that our system establishes stable and reproducible polymicrobial communities and facilitates analysis across both planktonic and biofilm lifestyles. We confirm that polymicrobial biofilms in this system display distinct population dynamics compared to planktonic populations and modulate the impact of ciprofloxacin treatment by protecting the most susceptible community members. In addition, we demonstrate the capacity of P. mirabilis to encrust and block catheters when part of a polymicrobial community and confirm that thioridazine treatment remains effective at inhibiting catheter blockage under these conditions.

Original languageEnglish
Article numberlxag098
Pages (from-to)1-12
Number of pages12
JournalJournal of Applied Microbiology
Volume137
Issue number5
DOIs
Publication statusPublished - 1 May 2026

Bibliographical note

© The Author(s) 2026. Published by Oxford University Press on behalf of Applied Microbiology International.

Data Availability Statement

All data underlying this article are available in the article and in its online material.

Funding

Medical Research Council Institutional Identifier: 501100000265 Grant Number: MR/N0137941/1

Keywords

  • Biofilms/drug effects
  • Urinary Tract Infections/microbiology
  • Catheter-Related Infections/microbiology
  • Humans
  • Anti-Bacterial Agents/pharmacology
  • Proteus mirabilis/drug effects
  • Coinfection/microbiology
  • Ciprofloxacin/pharmacology
  • Pseudomonas aeruginosa/drug effects
  • Enterococcus faecalis/drug effects
  • Escherichia coli/drug effects
  • Urinary Catheters/microbiology
  • Microbial Sensitivity Tests
  • Klebsiella pneumoniae/drug effects
  • Staphylococcus aureus/drug effects
  • Models, Biological
  • Bacteria/drug effects
  • Urinary Catheterization/adverse effects

Fingerprint

Dive into the research topics of 'A model of polymicrobial catheter-associated urinary tract infection reveals biofilm-mediated modulation of treatment efficacy'. Together they form a unique fingerprint.

Cite this